TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Long-Term Investments (2020 - 2023)

Updated

TFA Therapeutics' Long-Term Investments came in at $233,697 for Q4 2023, up 31.2% from $178,166 a year earlier and up 16.6% from the prior quarter.

Analysis

TFA Therapeutics (RAJAF) Long-Term Investments (2020 - 2023) Analysis & Trends

Going back to Q4 2020, TFA Therapeutics' Long-Term Investments data covers 5 quarters.

  • Long-Term Investments carries a three-year compound annual growth rate of 132.9% (FY2020 to FY2023).
  • Going back by year, Long-Term Investments was $178,166 in FY2022 (-34.5%), $272,216 in FY2021 and $18,502 in FY2020.
  • The Q4 2023 figure represents the highest quarterly Long-Term Investments since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Procter & Gamble 334.70 Bn 290.68 Bn 10.28 Bn -
2 Colgate Palmolive 67.39 Bn 62.44 Bn 3.30 Bn -
3 Kenvue 33.10 Bn 28.72 Bn 2.30 Bn -
4 Estee Lauder Companies 32.68 Bn 20.76 Bn 2.74 Bn -
5 Kimberly Clark 31.38 Bn 28.70 Bn 1.60 Bn 381.00 Mn
6 Church & Dwight 22.32 Bn 20.85 Bn 693.90 Mn 12.10 Mn
7 Clorox 9.75 Bn 8.19 Bn 804.00 Mn -
8 e.l.f. Beauty 6.14 Bn 5.11 Bn 398.84 Mn -
9 Reynolds Consumer Products 4.62 Bn 4.29 Bn 245.00 Mn -
10 TFA Therapeutics 1.02 Bn 1.02 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 233,697.00
Sep 30, 2023 200,384.00
Dec 31, 2022 178,166.00
Dec 31, 2021 272,216.00
Dec 31, 2020 18,502.00
API Access

TFA Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=RAJAF&period=max&api_key=YOUR_API_KEY